Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Parastoo Mirzabeigi"'
Autor:
Eilnaz Basardeh, Somayeh Piri-Gavgani, Hamid Reza Moradi, Masoumeh Azizi, Parastoo Mirzabeigi, Farzaneh Nazari, Mostafa Ghanei, Fereidoun Mahboudi, Fatemeh Rahimi-Jamnani
Publikováno v:
BMC Microbiology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The emergence of carbapenem-resistant and extensively drug-resistant (XDR) Acinetobacter baumannii as well as inadequate effective antibiotics calls for an urgent effort to find new antibacterial agents. The therapeutic efficacy o
Externí odkaz:
https://doaj.org/article/e3e282cbd10a4226ae2f2350c570918e
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 24, Iss 3 (2021)
Since the first production of monoclonal antibodies about 35 years ago, researchers have found them useful in the treatment and diagnosis of various diseases such as cancer. By developing different types of monoclonal antibodies such as humanized, dr
Externí odkaz:
https://doaj.org/article/9478118e2ecc4e38b4538732957095c6
Autor:
Atabak NAJAFI, Mojtaba MOJTAHEDZADEH, Niayesh MOHEBBI, Parastoo MIRZABEIGI, Legese CHELKEBA, Camelia RAMBOD, Farideh RAZI, Arezoo AHMADI
Publikováno v:
Iranian Journal of Public Health, Vol 44, Iss Supple 2 (2015)
To date, stem cell therapy is a novel treatment method especially in irreversible end organ damage. We present a case of a 21-yr-old man, who admitted in Sina Hospital, Tehran University of Medical Sciences, Iran with open left femur fracture followi
Externí odkaz:
https://doaj.org/article/80be59b381ce4784b8fd07e9d4a9fefc
Autor:
Hamed Montazeri, Hadi Bamehr, Leila Janani, Kiarash Tanha, Parastoo Mirzabeigi, Parastoo Tarighi
Publikováno v:
Drug research. 71(9)
Background Sitagliptin is known as an antidiabetic agent inhibiting the dipeptidyl peptidase-4. Although sitagliptin may influence weight, controversial results have been reported, and there is no general agreement on this issue. Therefore, this stud
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 24, Iss 3 (2021)
Since the first production of monoclonal antibodies about 35 years ago, researchers have found them useful in the treatment and diagnosis of various diseases such as cancer. By developing different types of monoclonal antibodies such as humanized, dr
Autor:
Milad Chizari, Samane Eftekhari, Parastoo Mirzabeigi, Parastoo Tarighi, Davod Jafari, Mahsa Sabernavaei
Publikováno v:
European Journal of Pharmacology
The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high prevalence and easy transmission, which is expanding globally with no conventional treatment or vaccine. The new virus revealed 79% and 50% genomic similarities with se
Autor:
Parastoo, Mirzabeigi, Amir Hooshang, Mohammadpour, Mojtaba, Salarifar, Kheirollah, Gholami, Mojtaba, Mojtahedzadeh, Mohammad Reza, Javadi
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
Numerous interventional studies in clinical and preclinical setting stated that intake of curcumin may provide protection against cardiovascular disease. The aim of this trial was investigation of curcumin efficiency on some cardiovascular risk facto
Publikováno v:
European journal of internal medicine. 24(3)
Background A clinical pharmacist is a key member of the antimicrobial multidisciplinary team involved in patients' pharmacotherapy monitoring. The aim of this study was to determine the frequency and type of medication errors, the type of clinical ph